Patrick McIlvenny - 11 Nov 2022 Form 3 Insider Report for Horizon Therapeutics Public Ltd Co

Role: Chief Accounting Officer
Signature: /s/ Patrick McIlvenny
Issuer symbol: N/A
Transactions as of: 11 Nov 2022
Net transactions value: $0
Form type: 3
Filing time: 14 Nov 2022, 15:13:10 UTC
Next filing: 06 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HZNP	Ordinary Shares						2,490	11 Nov 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HZNP	Restricted Stock Units (RSU)							11 Nov 2022	Ordinary Shares	3,871		Direct	F1
holding	HZNP	Restricted Stock Units (RSU)							11 Nov 2022	Ordinary Shares	4,396		Direct	F2
holding	HZNP	Restricted Stock Units (RSU)							11 Nov 2022	Ordinary Shares	5,713		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The 3,871 ordinary shares subject to the restricted stock units vest on January 5, 2023.
F2	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 2,198 ordinary shares subject to the restricted stock units vest on January 5, 2023; and 2,198 ordinary shares subject to the restricted stock units vest on January 5, 2024.
F3	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 1,904 ordinary shares subject to the restricted stock units vest on January 5, 2023; 1,904 ordinary shares subject to the restricted stock units vest on January 5, 2024; and 1,905 ordinary shares subject to the restricted stock units vest on January 5, 2025.